Update on acne

Current Opinion in Pediatrics

Volumn 10, Issue 4, 1998, Pages 381-386

  Degroot, Henry E ^a   Friedlander, Sheila Fallon ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; ERYTHROMYCIN; ISOTRETINOIN; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; RETINOL; SALICYLIC ACID; SULFACETAMIDE; TAZAROTENE; TETRACYCLINE;

ACNE VULGARIS; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION;

EID: 0031712579     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199808000-00010     Document Type: Review

References (45)

1. Thiboutot DM: Acne: An overview of clinical research findings. Dermatol Clin 1997, 15(1):97-109. Excellent review of acne covering topics from pathophysiology to therapy.
2. Karvonen SL, Rasanen L, Cunliffe WJ, et al.: Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans. Dermatol 1994, 189:344-349.
3. Jansen T, Burgdorf WHC, Plewig G: Pathogenesis and treatment of acne in childhood. Pediatr Dermatol 1997, 14(1):17-21.
4. Lucky AW: Hormonal correlates of acne and hirsutism. Am J Med 1995, 98(1A):89S-94S.
5. Tabata N, Terui T, Watanabe M: Infantile acne associated with a high plasma testosterone level in a 21-month-old boy. J Am Acad Dermatol 1995, 33:676-678.
6. Janniger CK: Neonatal and infantile acne vulgaris. Cutis 1993, 52(1):16.
7. Rothman KF: Acne update. Dermatol Ther 1997, 2:98-110. Practical information regarding acne therapy.
8. Leyden JJ: Oral isotretinoin. How can we treat difficult acne patients? Dermatol 1997, 195(suppl 1):29-33.
9. Lucky AW, Biro FM, Huster GA, et al.: Acne vulgaris in early adolescent boys: Correlations with pubertal maturation and age. Arch Dermatol 1991, 127:210-216.
10. Lucky AW, Biro FM, Huster GA, et al.: Acne vulgaris in premenarchal girls. Arch Dermatol 1994, 130:308-314.
11. De Raeve L, De Schepper J, Smite J: Prepubertal acne: A cutaneous marker of androgen excess? J Am Acad Dermatol 1995, 32:181-184.
12. Street ME, Camacho-Hubner C, Perry LA, et al.: Girls with virilisation in childhood: A diagnostic protocol for investigation. J Clin Pathol 1997, 50:379-383.
13. Coates P, Adams CA, Cunliffe WJ, et al.: Does oral isotretinoin prevent Propionibacterium acnes resistance? Dermatol 1997, 195(suppl 1):4-9.
14. Ross JI, Eady A, Cove JH, et al.: Clinical resistance to erythromycin and clindamycin in cutaneous Propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother 1997, 41(5):1162-1165.
15. Forssman T: Antibiotic resistance in acne patients under antibiotic treatment in comparison to an untreated control group with retrospective assessment of therapy. Curr Prob Dermatol 1995, 22:91-97.
16. Eady EA, Jones CE, Gardner KJ, et al.: Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br J Dermatol 1993, 128:556-560.
17. Eady EA, Farmery MR, Ross JI, et al.: Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994, 131:331-336.
18. Eady EA, Bojar RA, Jones CE, et al.: The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996, 134:107-113. Important documentation of benzoyl peroxide's utility in decreasing antimicrobial resistance.
19. Bolognia JL, Edelson RL: Spread of antibiotic-resistant bacteria from acne patients to personal contacts: A problem beyond the skin? Lancet 1997, 350(9083):972-973.
20. Leyden JJ: Therapy for acne vulgaris. N Engl J Med 1997, 336:1156-1162. Excellent overview of current views on therapy of acne.
21. Eady EA, Cove JH, Holland KT, Cunliffe WJ: Erythromycin resistant propionibacteria in antibiotic treated acne patients: Association with therapeutic failure. Br J Dermatol 1989, 121:51-57.
22. Weiss JS: Current options for the topical treatment of acne vulgaris. Pediatr Dermatol 1997, 14(6):480-488.
23. Shalita A, Weiss JS, Chalker DK, et al.: A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris. J Am Acad Dermatol 1996, 34:482-485.
24. Packman AM, Brown RH, Dunlap FE, et al.: Treatment of acne vulgaris: Combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion. Int J Dermatol 1996, 35(3):209-211.
25. Lookingbill DP, Chalker DK, Lindholm JS: Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: Combined results of two double-blind investigations. J Am Acad Dermatol 1997, 37:590-595.
26. Lucky AW, Henderson TA, Olson WH, et al.: Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997, 37:746-754. Landmark study of the use of oral contraceptives in acne therapy.
27. Seukeran DC, Eady EA, Cunliffe WJ: Benefit-risk assessment of acne therapies. Lancet 1997, 349:1251-1252.
28. Shapiro LE, Knowles SR, Shear NH: Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997, 133:1224-1230. Important review of rare but serious side effects of therapy with tetracyclines.
29. Knowles SR, Shapiro L, Shear NH: Serious adverse reactions induced by minocycline. Arch Dermatol 1996, 132:934-939.
30. Saurat JH: Oral isotretinoin. Where now, where next? Dermatol 1997, 195(suppl 1):1-3.
31. White GM: Recurrence rates after the first course of isotretinoin. Arch Dermatol 1998, 134:376-378.
32. Stainforth JM, Layton AM, Taylor JP, Cunliffe WJ: Isotretinoin for the treatment of acne vulgaris: Which factors may predict the need for more than one course? Br J Dermatol 1993, 129:297-301.
33. Layton AM, Knaggs H, Taylor J, Cunliffe WJ: Isotretinoin for acne vulgaris-10 years later: A safe and successful treatment. Br J Dermatol 1993, 129:292-296.
34. Ortonne JP: Oral isotretinoin treatment policy. Do we all agree? Dermatol 1997, 195(suppl 1):34-37.
35. Newton JN. How cost-effective is oral isotretinoin? Dermatol 1997, 195(suppl 1):10-14. Comprehensively addresses issues of cost control in acne therapy and utility of isotretinoin in this regard.
36. Goulden V, Clark SM, McGeown C, Cunliffe WJ: Treatment of acne vulgaris with intermittent isotretinoin. Br J Dermatol 1997, 137:106-108.
37. Karvonen SJ: Acne fulminans: Report of clinical findings and treatment of twenty-four patients. J Am Acad Dermatol 1993, 28:572-579.
38. Allison, MA, Dunn CL, Person DA: Acne fulminans treated with isotretinoin and "pulse" corticosteroids. Pediatr Dermatol 1997, 14(1):39-42. New approach to treatment of acne fulminans.
39. Oikarinen A, Autio P, Karvonen SL, et al.: Increased degradation of type I collagen in acne fulminans. Acta Derm Venereol 1996, 76:123-125.
40. Tan BB, Lear JT, Smith AG: Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone. Clin Exp Dermatol 1997, 22:26-27.
41. Lindor NM, Arsenault TM, Solomon H, et al.: A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997, 72:611-615.
42. Kurokawa S, Tokura Y, Nham X, et al.: Acne fulminans coexisting with pyoderma gangrenosum-like eruptions and posterior scleritis. J Dermatol 1996, 23:37-41.
43. Bolukbas N, Bolukbas S, Erel A, Tali T: SAPHO syndrome associated with acne fulminans and prominent acromioclavicular joint involvement. Scand J Rheumatol 1996, 25:180-182.
44. Erhardt E, Harangi F: Two cases of musculoskeletal syndrome associated with acne. Pediatr Dermatol 1997, 14(6):456-459.
45. Vignale R, Bonifazzio J, Aguirre B, Fleurquin F: Hormonal profile of acne vulgaris: New aspects of the androgen-dependent cutaneous syndrome, syndrome X. Int J Dermatol 1996, 35(2):94-95.